Glibert Christian Michael 4

What Happened
Glibert Christian Michael, identified as a 10% owner of ENvue Medical (FEED), purchased 240,000 shares in open-market transactions on January 14, 2026. The filing reports a weighted-average price of $2.67 per share, for a total reported purchase value of $640,800. This was a purchase (P) — generally considered a more informative/bullish signal than a sale, though no motive is stated.

Key Details

• Transaction date: 2026-01-14 (open-market purchases; transaction code P).
• Reported weighted-average price: $2.67; purchase price range per footnote: $2.47–$2.90 (multiple trades) (Footnote F1).
• Total shares acquired: 240,000; total reported cost: $640,800.
• Filing date: 2026-02-11 — filed about 28 days after the trades (appears to be later than the usual two-business-day Form 4 reporting window).
• Ownership note: the filer is identified as a 10% owner. The issuer’s outstanding share count used for percentage calculations is 1,088,192 (Footnote F2). The filing does not state the reporting person’s exact total shares held after this acquisition.

Context

• The filing is a direct purchase (not an option exercise, gift, or award). Footnote F1 states the price is a weighted average across multiple trades and the reporting person will provide details on request.
• Footnote F2 clarifies the outstanding share base (1,088,192) used for ownership percentages; the acquired 240,000 shares represent about 22.1% of that outstanding total, but the report itself lists the individual as a 10% owner and does not disclose post-trade total holdings.
• Because the filing appears late, investors may want to note timing when evaluating the signal; otherwise, the purchase is a straightforward insider buy disclosed on Form 4.